Human mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action of IL-4.

Mast cells have been implicated in the pathogenesis of fibrosis because of their increased number in chronic inflammatory reactions. In a previous study, we had shown that human mast cells readily attach and form heterotypic cell-cell contacts when seeded on top of fibroblast monolayers. Here, we report that human mast cells stimulate fibroblast proliferation after cell-cell contact. Proliferation was measured by 5-bromo-2'-deoxyuridine or [3H]thymidine uptake of subconfluent fibroblast monolayers after attachment of mast cells that had been preincubated with mitomycin C. An 18-h coculture of the human mast cell line HMC-1 doubled proliferation of normal skin fibroblasts. Moreover, normal mast cells prepared from neonatal foreskin doubled fibroblast proliferation. The stimulatory effect was dependent on heterotypic cell-cell contact since it was not transferred by tissue culture supernatants from mast cells. We hypothesized that mast cell cytokines secreted after heterotypic cell-cell contact stimulate fibroblast proliferation. Several mast cell-derived cytokines were tested for effects on fibroblast proliferation. Only IL-4 was able to double fibroblast proliferation. Additional experiments revealed that: 1) the stimulatory effect of IL-4 as well as of the mast cell coculture could be completely abrogated by preincubation of fibroblasts with an anti-IL-4R mAb blocking ligand binding; 2) mast cell-derived IL-4 acts as a second signal for fibroblasts since it amplifies the action of low doses of obligatory fibroblast growth factors such as fibroblast growth factor or platelet-derived growth factor.

[1]  J. Cairns,et al.  Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. , 1997, The Journal of clinical investigation.

[2]  E. Bröcker,et al.  Heterotypic cell-cell adhesion of human mast cells to fibroblasts , 1997, Archives of Dermatological Research.

[3]  M. Bennett,et al.  Intrahepatic mast cells in chronic liver diseases , 1995, Hepatology.

[4]  P. Valent,et al.  The riddle of the mast cell: kit(CD117)-ligand as the missing link? , 1994, Immunology today.

[5]  S. Galli,et al.  New concepts about the mast cell. , 1993, The New England journal of medicine.

[6]  P. Howarth,et al.  Interleukin 4 is localized to and released by human mast cells , 1992, The Journal of experimental medicine.

[7]  H. Katai,et al.  Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. , 1992, The Journal of clinical investigation.

[8]  J. Banchereau,et al.  Interleukin‐4 stimulates collagen gene expression in human fibroblast monolayer cultures Potential role in fibrosis , 1992, FEBS letters.

[9]  J. Banchereau,et al.  Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents. , 1992, Cellular and molecular biology.

[10]  M. Tsai,et al.  The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype , 1991, The Journal of experimental medicine.

[11]  A. Weinberg,et al.  IL-4 directs the development of Th2-like helper effectors. , 1990, Journal of immunology.

[12]  B. Masinovsky,et al.  IL-4 acts synergistically with IL-1 beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. , 1990, Journal of immunology.

[13]  C. Figdor,et al.  IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions. , 1989, Journal of immunology.

[14]  J. Monroe,et al.  Lymphokine regulation of inflammatory processes: interleukin-4 stimulates fibroblast proliferation. , 1988, Clinical immunology and immunopathology.

[15]  W. Paul,et al.  B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens. , 1987, Journal of immunology.

[16]  K. Nishioka,et al.  Mast cell numbers in diffuse scleroderma. , 1987, Archives of dermatology.

[17]  K. Austen,et al.  Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro. , 1985, Journal of immunology.

[18]  R. Clark,et al.  Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? , 1985, Annals of internal medicine.

[19]  S. Holgate,et al.  Cytokine production by human mast cells. , 1995, Chemical immunology.

[20]  E. Kovacs Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. , 1991, Immunology today.

[21]  G. Dewald,et al.  Establishment of an immature mast cell line from a patient with mast cell leukemia. , 1988, Leukemia research.